Irish leaders should anticipate that Trump will use the current crisis to argue that US companies have to produce and manufacture pharmaceuticals and medicines in the US, rather than in Ireland.


Why Trump’s tariff battle with China matters for the Irish pharma industry

The EU does not do megaphone diplomacy in the way that Trump does, however, it is likely to give Trump implicit support in the coming trade conflict with China. One loser could be Ireland’s pharma industry.

13th May, 2020 - 6 min read

In recent weeks, US President Donald Trump raised the possibility of implementing tariff measures as a means of punishing China for its behaviour in relation to the Covid-19 outbreak. Trump claims to have seen evidence of a link between a laboratory in Wuhan and the outbreak of the virus. US intelligence agencies have said no such evidence exists at this time, so investors simply believed that Trump was engaging in his usual bellicose rhetoric, possibly to divert attention from the US’ lamentable response to the Covid-19 pandemic.

However, there are a number of short term and longer-term considerations which suggest that there is more to...

© 2020 Currency Media Limited